Immunology

Local allergic rhinitis often progresses over time

(HealthDay)—Patients with local allergic rhinitis (LAR) show worsening of rhinitis, greater tendency toward development of asthma, and impairment of quality of life after 10 years, but have a similar rate of development ...

Immunology

Scientists unearth cell 'checkpoint' that stops allergic diseases

Scientists from Trinity College Dublin have made a significant breakthrough in understanding the regulation of immune cells that play a pivotal role in allergic diseases such as asthma and eczema. They have identified a 'checkpoint' ...

Immunology

Cost-effectiveness of allergen immunotherapy evaluated

(HealthDay)—Allergen immunotherapy (AIT) may be cost-effective for allergic rhinitis, and for venom allergy in high-risk subgroups, according to research published online July 18 in Allergy.

Immunology

Pollutant exposure may lead to multi-generational asthma risk

(HealthDay)—Maternal exposure to diesel exhaust particles during pregnancy may increase susceptibility to allergic asthma in more than one generation of offspring, according to an experimental study published online recently ...

Immunology

Short-term benefits for immunotherapy in allergic asthma

(HealthDay)—Administration of allergen immunotherapy (AIT) in patients with allergic asthma leads to lower short-term symptom and medication scores, according to a review published online May 19 in Allergy.

page 8 from 18